| Key Financial Ratios of Glenmark Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
57.07 |
183.13 |
42.84 |
70.80 |
58.46 |
|
| Diluted EPS (Rs.) |
57.07 |
183.13 |
42.84 |
70.80 |
58.46 |
|
| Cash EPS (Rs.) |
64.81 |
190.29 |
49.36 |
76.46 |
63.80 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
868.35 |
814.07 |
633.57 |
593.21 |
524.84 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
868.35 |
814.07 |
633.57 |
593.21 |
524.84 |
|
| Dividend / Share(Rs.) |
2.50 |
2.50 |
2.50 |
2.50 |
2.50 |
|
| Revenue from Operations/Share (Rs.) |
326.96 |
279.66 |
291.34 |
288.53 |
268.20 |
|
| PBDIT/Share (Rs.) |
92.16 |
85.40 |
87.14 |
81.61 |
81.04 |
|
| PBIT/Share (Rs.) |
84.41 |
78.23 |
80.61 |
75.95 |
75.69 |
|
| PBT/Share (Rs.) |
76.33 |
248.10 |
55.71 |
82.84 |
68.89 |
|
| Net Profit/Share (Rs.) |
57.07 |
183.13 |
42.84 |
70.80 |
58.46 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
28.18 |
30.53 |
29.90 |
28.28 |
30.21 |
|
| PBIT Margin (%) |
25.81 |
27.97 |
27.66 |
26.32 |
28.22 |
|
| PBT Margin (%) |
23.34 |
88.71 |
19.12 |
28.70 |
25.68 |
|
| Net Profit Margin (%) |
17.45 |
65.48 |
14.70 |
24.53 |
21.79 |
|
| Return on Networth / Equity (%) |
6.57 |
22.49 |
6.76 |
11.93 |
11.13 |
|
| Return on Capital Employed (%) |
9.60 |
9.54 |
10.86 |
11.00 |
11.79 |
|
| Return on Assets (%) |
5.74 |
18.84 |
4.91 |
8.71 |
8.00 |
|
| Total Debt/Equity (X) |
0.03 |
0.03 |
0.18 |
0.22 |
0.24 |
|
| Asset Turnover Ratio (%) |
0.33 |
0.30 |
0.35 |
0.37 |
0.38 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.47 |
1.09 |
1.20 |
1.28 |
1.96 |
|
| Quick Ratio (X) |
1.05 |
0.83 |
0.90 |
1.00 |
1.66 |
|
| Inventory Turnover Ratio (X) |
7.35 |
2.68 |
2.97 |
3.49 |
3.35 |
|
| Dividend Payout Ratio (NP) (%) |
4.38 |
1.36 |
5.83 |
3.53 |
4.27 |
|
| Dividend Payout Ratio (CP) (%) |
3.85 |
1.31 |
5.06 |
3.26 |
3.91 |
|
| Earnings Retention Ratio (%) |
95.62 |
98.64 |
94.17 |
96.47 |
95.73 |
|
| Cash Earnings Retention Ratio (%) |
96.15 |
98.69 |
94.94 |
96.74 |
96.09 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
44,024.75 |
27,545.86 |
16,183.51 |
16,118.27 |
16,718.02 |
|
| EV/Net Operating Revenue (X) |
4.77 |
3.49 |
1.97 |
1.98 |
2.21 |
|
| EV/EBITDA (X) |
16.93 |
11.43 |
6.58 |
7.00 |
7.31 |
|
| MarketCap/Net Operating Revenue (X) |
4.71 |
3.42 |
1.60 |
1.53 |
1.73 |
|
| Retention Ratios (%) |
95.61 |
98.63 |
94.16 |
96.46 |
95.72 |
|
| Price/BV (X) |
1.77 |
1.18 |
0.73 |
0.75 |
0.89 |
|
| Price/Net Operating Revenue |
4.71 |
3.42 |
1.60 |
1.53 |
1.73 |
|
| Earnings Yield |
0.04 |
0.19 |
0.09 |
0.16 |
0.13 |
|
Source : Dion Global Solutions Limited
